Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 240-245

  De Winter, Robbert J ^a   Bholasingh, Radha ^a   Lijmer, Jeroen G ^a   Koster, Rudolph W ^a   Gorgels, Jozef P M C ^a   Schouten, Yvonne ^a   Hoek, Frans J ^a   Sanders, Gerard T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Acute coronary syndromes; C reactive protein; Prognosis; Troponin I

Indexed keywords

C REACTIVE PROTEIN; TROPONIN I;

ADULT; AGED; ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; RISK ASSESSMENT; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; TROPONIN I;

EID: 0032897464     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00018-8     Document Type: Article

References (25)

1. Wallentin L. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet. 336:1990;827-830.
2. Theroux P., Waters D., Qui S., McCans J., de Guise P., Juneau M. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation. 88:1993;2045-2048.
3. Braunwald E. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Circulation. 89:1994;1545-1556.
4. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. New Engl J Med. 327:1994;146-150.
5. Stubbs P., Collinson P., Moseley D., Greenwood T., Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation. 94:1996;1291-1297.
6. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657.
7. Ohman E.M., Armstrong P.W., Christenson R.H., et al. Cardiac troponin T levels for risk stratification in acute myocardial infarction. New Engl J Med. 335:1996;1333-1341.
8. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med. 335:1996;1342-1349.
9. Galvani M., Ottani F., Ferrini D., et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation. 95:1997;2053-2059.
10. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Eng J Med. 331:1994;417-424.
11. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
12. Liuzzo G., Biasucci L.M., Rebuzzi A.G., et al. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury. Circulation. 94:1996;2373-2380.
13. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 349:1997;462-466.
14. World Health Organization criteria for the diagnosis of acute myocardial infarction. Proposal for the multinational monitoring of trends and determinants in cardiovascular disease. Geneva: Cardiovascular Disease Unit of WHO, 1981.
15. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) Phase II Trial. New Engl J Med. 320:1989;618-627.
16. Hosmer D.W. Jr., Lemeshow S. Applied logistic regression. 1989;30-33 Wiley, New York.
17. Boyd J.C. Mathematical tools for demonstrating the clinical usefulness of biochemical markers. Scan J Clin Lab Invest. 57:(Suppl 227):1997;46-63.
18. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol. 31:1998;1460-1465.
19. Toss H., Lindahl B., Siegbahn A., Wallentin L. for the FRISC study group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 96:1997;4204-4210.
20. Kanda T., Hirao Y., Oshima S., et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol. 77:1996;304-307.
21. Maury C.P.J., Teppo A.M. Circulating tumor necrosis factor-alpha (cachectin) in myocardial infarction. J Int Med. 225:1989;333-336.
22. Manten A., DeWinter R.J., Minnema M.C., et al. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res. 40:1998;389-395.
23. Cermak J., Key N.S., Bach R.R., Balla J., Jacob H.S., Vercelotti G.M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 82:1993;513-520.
24. Hack C.E., Wolbink G.J., Schalkwijk C., Speijer H., Hermens W.T., van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. [Review]. Immunol Today. 18:1997;111-115.
25. van der Wal A., Becker A.E., van der Loos C., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.